Literature DB >> 19184169

Is left ventricular noncompaction in children truly an isolated lesion?

Shane F Tsai1, Eric S Ebenroth, Roger A Hurwitz, Timothy M Cordes, Marcus S Schamberger, Anjan S Batra.   

Abstract

Left ventricular noncompaction (LVNC) is a form of cardiomyopathy resulting from a disorder of endomyocardial morphogenesis. It has been associated with significant morbidity and mortality. The aim of this study was to characterize associated cardiac findings in children with LVNC and to identify risk factors associated with increased mortality. From our echocardiography database, we identified 46 patients diagnosed with LVNC between December 1999 and February 2005. The mean age at presentation was 3.6 +/- 5.6 years, and the mean duration of follow-up was 1.9 +/- 2.1 years. Left ventricular ejection fraction was decreased in 24 patients (52%; mean 39.5% +/- 13.1%). Thirty-six patients (78%) had associated cardiac lesions, including atrial septal defect (n = 16 [35%]), ventricular septal defect (n = 17 [37%]), patent ductus arteriosus (n = 14 [30%]), and Ebstein's anomaly (n = 5 [11%]). Electrocardiogram abnormalities were found in 80% of patients; most commonly they included left (n = 15 [43%]) and right ventricular hypertrophy (n = 19 [54%]). Documented arrhythmias included ectopic atrial rhythm (n = 2), junctional rhythm (n = 2), supraventricular tachycardia (n = 2), and ventricular tachycardia (n = 1). Overall mortality was 20%, and there was no association with ejection fraction, morphologic defect, or arrhythmia. Mean age at diagnosis in survivors (4.5 +/- 6.1 years) was higher than nonsurvivors (0.4 +/- 0.7 years) (p < 0.0001). LVNC is a rarely isolated form of cardiomyopathy, and it is associated with significant additional cardiac abnormalities. Although it does not have an invariably fatal course, early presentation in infancy does carry an increased risk of mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19184169     DOI: 10.1007/s00246-008-9382-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction.

Authors:  Rui Chen; Tohru Tsuji; Fukiko Ichida; Karla R Bowles; Xianyi Yu; Sayaka Watanabe; Keiichi Hirono; Shinichi Tsubata; Yuji Hamamichi; Jun Ohta; Yasuharu Imai; Neil E Bowles; Toshio Miyawaki; Jeffrey A Towbin
Journal:  Mol Genet Metab       Date:  2002-12       Impact factor: 4.797

2.  Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis.

Authors:  E N Oechslin; C H Attenhofer Jost; J R Rojas; P A Kaufmann; R Jenni
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

3.  Two-layered appearance of noncompaction of the ventricular myocardium on magnetic resonance imaging.

Authors:  Yumiko Daimon; Shigeru Watanabe; Shinichi Takeda; Yasuyoshi Hijikata; Issei Komuro
Journal:  Circ J       Date:  2002-06       Impact factor: 2.993

4.  Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients.

Authors:  Sabine Sasse-Klaassen; Brenda Gerull; Erwin Oechslin; Rolf Jenni; Ludwig Thierfelder
Journal:  Am J Med Genet A       Date:  2003-06-01       Impact factor: 2.802

5.  MR appearance of isolated noncompaction of the left ventricle.

Authors:  T F Hany; R Jenni; J F Debatin
Journal:  J Magn Reson Imaging       Date:  1997 Mar-Apr       Impact factor: 4.813

6.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

7.  Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.

Authors:  F Ichida; Y Hamamichi; T Miyawaki; Y Ono; T Kamiya; T Akagi; H Hamada; O Hirose; T Isobe; K Yamada; S Kurotobi; H Mito; T Miyake; Y Murakami; T Nishi; M Shinohara; M Seguchi; S Tashiro; H Tomimatsu
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

8.  Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity.

Authors:  Yanlin Xing; Fukiko Ichida; Taro Matsuoka; Takeshi Isobe; Yumiko Ikemoto; Takashi Higaki; Tohru Tsuji; Noriyuki Haneda; Atsushi Kuwabara; Rui Chen; Takeshi Futatani; Shinichi Tsubata; Sayaka Watanabe; Kazuhiro Watanabe; Keiichi Hirono; Keiichiro Uese; Toshio Miyawaki; Karla R Bowles; Neil E Bowles; Jeffrey A Towbin
Journal:  Mol Genet Metab       Date:  2006-01-19       Impact factor: 4.797

9.  Rhythm abnormalities in children with isolated ventricular noncompaction.

Authors:  Alpay Celiker; Süheyla Ozkutlu; Embiya Dilber; Tevfik Karagöz
Journal:  Pacing Clin Electrophysiol       Date:  2005-11       Impact factor: 1.976

10.  Isolated noncompaction of left ventricular myocardium. A study of eight cases.

Authors:  T K Chin; J K Perloff; R G Williams; K Jue; R Mohrmann
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

View more
  17 in total

1.  Left-ventricular noncompaction in a pediatric population: predictors of survival.

Authors:  Warren A Zuckerman; Marc E Richmond; Rakesh K Singh; Sheila J Carroll; Thomas J Starc; Linda J Addonizio
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  Electrocardiographic findings at initial diagnosis in children with isolated left ventricular noncompaction.

Authors:  Yakup Ergul; Kemal Nisli; Muhammet Ali Varkal; Naci Oner; Memduh Dursun; Aygun Dindar; Umrah Aydogan; Rukiye Eker Omeroglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

Review 3.  Left ventricular non-compaction and its cardiac and neurologic implications.

Authors:  Josef Finsterer
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

4.  Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.

Authors:  Marja W Wessels; Johanna C Herkert; Ingrid M Frohn-Mulder; Michiel Dalinghaus; Arthur van den Wijngaard; Ronald R de Krijger; Michelle Michels; Irenaeus Fm de Coo; Yvonne M Hoedemaekers; Dennis Dooijes
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

5.  Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Peter Jirak; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-16       Impact factor: 1.468

6.  Quantitative electrocardiographic measures, neuromuscular disorders, and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05       Impact factor: 1.468

7.  Non-compaction of the left ventricle and associated ventricular septal defect.

Authors:  Abid Hussain Laghari; Javed Majid Tai; Sumaira Saleem
Journal:  BMJ Case Rep       Date:  2012-10-06

8.  A teenager with Marfan syndrome and left ventricular noncompaction.

Authors:  David Kwiatkowski; Sean Hagenbuch; Richard Meyer
Journal:  Pediatr Cardiol       Date:  2009-10-01       Impact factor: 1.655

9.  Noncompaction cardiomyopathy. Is it more than noncompaction?

Authors:  A Kalayci; Y Guler; C Y Karabay; A Guler; S M Aung; C Kirma
Journal:  Herz       Date:  2012-09-08       Impact factor: 1.443

Review 10.  Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

Authors:  Steven E Lipshultz; Thomas R Cochran; David A Briston; Stefanie R Brown; Peter J Sambatakos; Tracie L Miller; Adriana A Carrillo; Liat Corcia; Janine E Sanchez; Melissa B Diamond; Michael Freundlich; Danielle Harake; Tamara Gayle; William G Harmon; Paolo G Rusconi; Satinder K Sandhu; James D Wilkinson
Journal:  Future Cardiol       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.